Exelixis: A Notable Quarter

Group 1 - The biotech forum has seen significant discussions around profitable buy-write or covered call strategies on selected biotech stocks in recent quarters [1] - Exelixis, Inc. (NASDAQ: EXEL) reported strong first-quarter results and significantly raised its forward guidance [2] - The company is undergoing a long-term transition as it prepares for leadership changes [2]